newsfilter
← Latest News
PR Newswire·

World-Premier Cancer Center Sheba Medical Center Selects Entolimod for Clinical Trial, Potentially Expanding Valion Bio into the Multi-Billion-Dollar Neutropenia Market

Valion Bio, Inc. (Nasdaq: VBIO) today announced a major clinical development milestone with the finalization of an clinical trial protocol at Sheba...